Merck & Co.
213 E Grand Avenue, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA 02141
United States
4225 articles about Merck & Co.
-
Merck & Co., Inc. to Hold Second-Quarter 2009 Sales and Earnings Conference Call on July 21
6/2/2009
-
Microsoft Signs Agreement With Merck & Co., Inc. to Acquire Assets of Rosetta Biosoftware, Strengthening Position in Life Sciences Industry
6/1/2009
-
Merck & Co., Inc. to Present Clinical Data on Oncology Pipeline Candidates at American Society of Clinical Oncology 2009
5/29/2009
-
Schering-Plough Corporation and Merck & Co., Inc. Provide Update on Distribution Agreement
5/28/2009
-
Merck & Co., Inc. Announces Third-Quarter 2009 Dividend
5/28/2009
-
Merck & Co., Inc.: GARDASIL(R) is First Cervical Cancer Vaccine to Receive World Health Organization Pre-qualification
5/26/2009
-
Merck & Co., Inc. to Launch TREDAPTIVE(TM) (ER niacin/laropiprant) in International Markets Later This Year
5/19/2009
-
Cardiome Pharma Corp., Merck & Co., Inc. (JOBS) Agreement Now Effective; Triggers Initial Payment of $60 Million to Cardiome
5/19/2009
-
Studies of GARDASIL(R), Merck & Co., Inc.'s Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at International Papillomavirus Conference
5/8/2009
-
GlaxoSmithKline Study Shows Its Cancer Shot Beats Merck & Co., Inc.'s (JOBS)
5/8/2009
-
Asthma & COPD Drug Producers Schering-Plough Corporation, Merck & Co., Inc., AstraZeneca PLC and GlaxoSmithKline Explore Advances in the Drug Development Market
5/5/2009
-
SEC Probes Schering-Plough Corporation (JOBS) Trades Ahead of Merck & Co., Inc. (JOBS) Deal
5/1/2009
-
Top Schering-Plough Corporation Executives Could Get $132 Million in Merck & Co., Inc. Deal Jackpot
4/30/2009
-
Merck & Co., Inc. Engages PharmaVentures Ltd to Assist in the Divestment of its Italian Research Centre IRBM
4/24/2009
-
Merck & Co., Inc. Accused of 'Ghost Writing' Medical Article
4/24/2009
-
CIGNA Corporation And Merck & Co., Inc. Sign Performance-Based Contract
4/23/2009
-
Merck & Co., Inc. Signs Licensing Deal; Medarex, Inc. and Massachusetts Biologic Laboratories to Get Payments up to $165 Million
4/21/2009
-
Merck & Co., Inc. Profit Falls Short, Shares Slump 3 Percent
4/21/2009
-
Galapagos NV Signs Merck & Co., Inc. (JOBS) Deal That Could Be Worth $251.7 Million; Shares Leap
4/20/2009
-
Merck & Co., Inc. and Santen, Inc. Sign Licensing Agreement In Ophthalmology
4/15/2009